Table 2.
Patient characteristics per disease group and year of admission
| Variable | Disease group | |||||
|---|---|---|---|---|---|---|
| TBI (n = 123) | SAH (n = 101) | |||||
| 2019 (n = 56) | 2020 (n = 67) | p value | 2019 (n = 49) | 2020 (n = 52) | p value | |
| Interval | ||||||
| Early | 31 (55%) | 33 (49%) | 0.500 | 22 (45%) | 28 (54%) | 0.369 |
| Late | 25 (45%) | 34 (51%) | 27 (55%) | 24 (26%) | ||
| Age (median (IQR)) | 63 (54, 72) | 60 (41, 72) | 0.416 | 58 (49, 70) | 55 (48, 67) | 0.394 |
| Female (n (%)) | 13 (23%) | 13 (19%) | 0.606 | 31 (63%) | 32 (62%) | 0.858 |
| GCS score (n (%)) | ||||||
| 3–8 | 22 (39%) | 21 (31%) | 0.402 | 17 (35%) | 16 (31%) | 0.901 |
| 9–12 | 14 (25%) | 14 (21%) | 4 (8%) | 4 (8%) | ||
| 13–15 | 20 (36%) | 32 (48%) | 28 (57%) | 32 (61%) | ||
| Pupillary light reaction (n (%)) | ||||||
| Normal | 45 (80%) | 58 (87%) | 0.353 | 42 (86%) | 37 (71%) | 0.076 |
| Abnormal | 11 820%) | 9 (13%) | 7 (14%) | 15 (29%) | ||
| TBI operative treatment | ||||||
| Craniotomy or decompressive craniectomy | 31 (55%) | 32 (47%) | 0.401 | NA | NA | NA |
| Aneurysm treatment | ||||||
| Endovascular | NA | NA | NA | 26 (53%) | 38 (73%) | 0.111 |
| Microsurgical | NA | NA | NA | 14 (29%) | 9 (17%) | |
| No treatmenta | NA | NA | NA | 9 (18%) | 5 (10%) | |
| Days in ICU (median (IQR)) | 4 (2, 7) | 3 (2, 8) | 0.869 | 8 (4, 14) | 9 (3, 13) | 0.923 |
| SARS-CoV-2 testedb (n (%)) | NA | 11 (16%) | NA | NA | 13 (25%) | NA |
| SARS-CoV-2 positivec (n (%)) | NA | 0 (0%) | NA | NA | 0 (0%) | NA |
Abbreviation: GCS, Glasgow Coma Scale; TBI, traumatic brain injury; SAH, aneurysmal subarachnoid hemorrhage
aIn all cases aneurysm treatment was withheld due to dismal prognosis
bTested during the initial admission
cOf SARS-CoV-2 tested